A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery
Advanced Science · 2025-04 · 12 (16)
DOI: 10.1002/advs.202412402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.03.2025. Verfasst von Qing Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Control Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China. Hauptthemen laut MEDLINE: Drug Discovery, COVID-19 Drug Treatment, Machine Learning. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Discovering therapeutic molecules requires the integration of both phenotype‐based drug discovery (PDD) and target‐based drug discovery (TDD). However, this integration remains challenging due to the inherent heterogeneity, noise, and bias present in biomedical data. In this study, Knowledge‐Guided Drug Relational Predictor (KGDRP), a graph representation learning approach is developed that effectively integrates multimodal biomedical data, including network data containing biological system information, gene expression data, and sequence data that incorporates chemical molecular structures, all within a heterogeneous graph (HG) structure. By incorporating biomedical HG (BioHG) into a heterogeneous graph neural network (HGNN)‐based architecture, KGDRP exhibits a remarkable 12% improvement compared to previous methods in real‐world screening scenarios. Notably, the biology‐informed representation, derived from KGDRP, significantly enhance target prioritization by 26% in drug target discovery. Furthermore, zero‐shot evaluation on COVID‐19 exhibited a notably higher success rate in identifying diverse potential drugs. The utilization of BioHG facilitates a unique KGDRP‐based analysis of cell‐target‐drug interactions, thereby enabling the elucidation of drug mechanisms. Overall, KGDRP provides a robust infrastructure for the seamlessly integration of multimodal data and biomedical networks, effectively accelerating PDD, guiding therapeutic target discovery, and ultimately expediting therapeutic molecule discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Control Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- CarbonSilicon AI Technology Co., Ltd, Hangzhou, Zhejiang, 310018, China.
- Center for Intelligent and Biomimetic Systems, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 440305, China.
ORCID-Profile: Tingjun Hou
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Ye, Q., Zeng, Y., Jiang, L., Kang, Y., Pan, P., Chen, J., Deng, Y., Zhao, H., He, S., Hou, T., & Hsieh, C. Y. (2025). A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery. Advanced Science, 12(16). https://doi.org/10.1002/advs.202412402
Vancouver
Ye Q, Zeng Y, Jiang L, Kang Y, Pan P, Chen J, et al. A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery. Advanced Science. 2025;12(16). doi:10.1002/advs.202412402
BibTeX
@article{Ye2025,
author = {Ye, Qing and Zeng, Yundian and Jiang, Linlong and Kang, Yu and Pan, Peichen and Chen, Jiming and Deng, Yafeng and Zhao, Haitao and He, Shibo and Hou, Tingjun and Hsieh, Chang-Yu},
title = {A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {16},
doi = {10.1002/advs.202412402}
}
EUVIMED